247 related articles for article (PubMed ID: 7080994)
1. Immunologic study of carcinoma of the digestive tract. Effects of the tumor stage. I. Cellular immunity in the preoperative period.
Sanz ML; Subirá ML; Oehling A; Hernández JL; Zornoza G
Allergol Immunopathol (Madr); 1982; 10(1):33-42. PubMed ID: 7080994
[TBL] [Abstract][Full Text] [Related]
2. [Determination of the lymphocytic and oncofetal antigen subpopulations in patients with adenocarcinomas of the stomach and of the colon and rectum (author's transl)].
Voltas J; Sanz ML; Hernández JL; Crisci CD; Subirá ML; Zornoza G
Med Clin (Barc); 1979 Dec; 73(10):419-23. PubMed ID: 93670
[TBL] [Abstract][Full Text] [Related]
3. Immunologic study of carcinoma of the digestive tract. Influence of tumor staging. II. Humoral immunity in the preoperative period.
Sanz ML; Oehling A; Subirá ML; Hernández JL; Lera JM; Zornoza G
Allergol Immunopathol (Madr); 1982; 10(2):95-100. PubMed ID: 7102489
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subpopulations in colo-rectal cancer. Preoperative evaluation.
Hernández JL; Sanz ML; Crisci CD; Voltas J; Subirá ML; Zornoza G; Oehling A
Allergol Immunopathol (Madr); 1978; 6(4):339-44. PubMed ID: 310638
[TBL] [Abstract][Full Text] [Related]
5. [In vitro studies of autologous and allogeneic recognition in patients with gastric and colorectal adenocarcinoma].
Machado I; Cabrera L; Anderson C; Meilijson O; Pérez L; Bianco N
G E N; 1985; 39(1):1-19. PubMed ID: 2939005
[No Abstract] [Full Text] [Related]
6. Enhancement of lymphocyte-mediated cytotoxicity after tumor resection in patients with colorectal cancer.
Waller CA; Gill PG; MacLennan IC
J Natl Cancer Inst; 1980 Aug; 65(2):223-30. PubMed ID: 6931244
[TBL] [Abstract][Full Text] [Related]
7. [Cellular immunity indices in rectal cancer under surgical and combined treatment].
Evsev'eva AI; Mosienko MD; Zybina MA; Umanskiĭ IuA
Vopr Onkol; 1981; 27(6):40-4. PubMed ID: 7269416
[TBL] [Abstract][Full Text] [Related]
8. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
Karanikas V; Hwang LA; Pearson J; Ong CS; Apostolopoulos V; Vaughan H; Xing PX; Jamieson G; Pietersz G; Tait B; Broadbent R; Thynne G; McKenzie IF
J Clin Invest; 1997 Dec; 100(11):2783-92. PubMed ID: 9389743
[TBL] [Abstract][Full Text] [Related]
9. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
Muhrer KH; Kahle M; Pasurka B
Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
[TBL] [Abstract][Full Text] [Related]
10. Some immunologic characteristics of carcinoma of the colon and rectum.
Elias EG; Elias LL
Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte subpopulations in gastric cancer. Preoperative evaluation.
Sanz ML; Crisci CD; Hernández JL; Subirá ML; Voltas J; Zornoza G; Oehling A
Allergol Immunopathol (Madr); 1978; 6(5):415-22. PubMed ID: 311148
[No Abstract] [Full Text] [Related]
12. In vitro cell-mediated immune reactivity in colon cancer patients.
Markova R; Argirova R; Boeva M
Neoplasma; 1982; 29(5):567-72. PubMed ID: 7177246
[TBL] [Abstract][Full Text] [Related]
13. Some parameters of cell-mediated immunity in colon cancer patients.
Markova R; Argirova R; Boeva M
Neoplasma; 1980; 27(1):43-6. PubMed ID: 6966380
[TBL] [Abstract][Full Text] [Related]
14. The significance of cytotoxicity of lymphocyte populations in coloncarcinoma patients in comparison to normal controls using a new statistical method of evaluation.
Warnatz H; Eder E; Lackner D; Hommel G
Z Immunitatsforsch Immunobiol; 1977 Jul; 153(2):128-42. PubMed ID: 906620
[TBL] [Abstract][Full Text] [Related]
15. [Skin sensitization of costus root oil and peripheral lymphocyte count in gastric and colon cancers].
Takanami I; Utsunomiya T; Ohnishi H; Shinohara H; Bessho T; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):81-6. PubMed ID: 6696456
[TBL] [Abstract][Full Text] [Related]
16. Activation of human peritoneal immune cells in early stages of gastric and colon cancer.
Olszewski WL; Kubicka U; Tarnowski W; Bielecki K; Ziolkowska A; Wesolowska A
Surgery; 2007 Feb; 141(2):212-21. PubMed ID: 17263978
[TBL] [Abstract][Full Text] [Related]
17. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract][Full Text] [Related]
18. [Status of T-system immunity in patients with chronic diseases and cancer of the gastrointestinal tract].
Movsesian KS; Voĭtenkov BO; Mel'nikov RA; Evtiukhin AI; Stefanenko IuF
Vopr Onkol; 1985; 31(1):60-3. PubMed ID: 3871990
[TBL] [Abstract][Full Text] [Related]
19. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
Muhrer KH; Schwemmle K; Filler D; Kahle M
Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
[TBL] [Abstract][Full Text] [Related]
20. Increased monocyte phagocytosis and decreased lymphocyte mitogen reactivity in colorectal cancer patients.
Ruco LP; Procopio A; Valtieri M; Uccini S; Chirletti P; Baroni CD
Appl Pathol; 1983; 1(3):149-56. PubMed ID: 6678592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
